Publication | Closed Access

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

Neurodegenerative DiseasesAlzheimer's DiseaseInsulin SignallingMedicineDementiaVascular DementiaNeurochemical BiomarkersNeuroscienceNeurologyNeurodegenerationInsulin ReceptorAging-associated DiseaseIgf-1 ReceptorInsulin Signaling